Patents
Patents for C07C 255 - Carboxylic acid nitriles (27,066)
02/2003
02/18/2003CA2420042A1 Carboxylic acid derivatives, processes for the preparation thereof and pharmaceutical agents comprising the same as active ingredient
02/18/2003CA2073042C Phenylethanolamines, drugs containing these compounds, and a method of preparing them
02/13/2003WO2003011817A1 1, 3, 5-tricyano-2, 4, 6-tris(vinyl)benzene derivatives and method for preparing the same
02/13/2003WO2003011807A1 Novel vinyl carboxylic acid derivatives and their use as antidiabetics etc.
02/13/2003WO2003011804A2 Method for producing partial (amm)oxidation products of an olefin
02/13/2003WO2003011457A1 Catalyst system containing ni(0) for hydrocyanation
02/13/2003WO2003011210A2 Arylheteroalkylamine derivatives and their use as inhibitors of nitric oxide synthase
02/13/2003WO2002092551A3 Copper-catalyzed vapor phase hydrocyanation of diolefinic compounds
02/13/2003US20030032833 Depolymerization; using thin film wiping evaporator
02/13/2003US20030032832 Use of diamines and alkanolamines to inhibit unsaturated monomer polymerization
02/13/2003US20030032810 Antagonists of natural killer cell-3 receptors
02/13/2003US20030032802 IL8-receptor antagonists
02/13/2003US20030032670 Monohydrate of cis-lithium-cyano-4-[3-(cyclopentyloxy)-4-methoxyphenyl)cyclohexanecarboxylate
02/13/2003US20030032644 Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity
02/13/2003US20030031691 Topical sunscreens for hair or skin
02/13/2003US20030030035 Polymerization inhibitor for vinyl-containing materials
02/13/2003CA2454912A1 Catalyst system containing ni(0) for hydrocyanation
02/13/2003CA2452665A1 Novel vinyl carboxylic acid derivatives and their use as antidiabetics etc.
02/12/2003EP1283521A2 Optical information recording medium and novel immonium compound
02/12/2003EP1282596A1 Preparation of iminodiacetic acid compounds from monoethanolamine substrates
02/12/2003EP1032566B1 Method for the preparation of citalopram
02/12/2003CN1396928A Process for preparation of acetyl-amidiniophenylalanyl-cyclohexylglycyl-pyridinioalaninamides
02/12/2003CN1396907A 3-phenoxy-1-phenyl acetylene derivatives and their use as herbicides
02/12/2003CN1396906A Calcilytic compounds
02/12/2003CN1396905A Asymmetric synthesis (S)-(+)-3-(aminomethyl)-5-methylhexanoic
02/12/2003CN1396819A Novel coupler for use in oxidative hair dyeing
02/12/2003CN1395997A Hydrothermal synthesis MO-V-M-X oxide catalyst for selective hydrocarbon oxide
02/12/2003CN1395996A Single crystalline phase catalyst
02/11/2003US6518449 Method for regenerating a hydrogenation catalyst, method for hydrogenating compounds comprising nitrile functions
02/11/2003US6518326 Open chain alkoxyamine compounds and their use as polymerization regulators
02/11/2003US6518283 Squaric acid derivatives
02/11/2003US6517739 Ferulic acid derivative, and liquid crystal material, cation detecting element, anion detecting element, ion conducting material and electrolyte, each using the ferulic acid derivative
02/11/2003CA2041818C Separation of enantiomers of cimaterol, (-)-cimaterol and the use thereof as pharmaceutical compositions or as performance enhancers
02/10/2003WO2002014263A1 Acylacetonitriles, process for preparation thereof and miticides containing the same
02/06/2003WO2003010148A1 Pyrazoline derivatives and their use as pesticides
02/06/2003WO2003009807A2 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods
02/06/2003US20030027859 3-aryl-2-hydroxypropionic acid derivative I
02/06/2003US20030027840 Estrogen receptor modulators
02/06/2003US20030026521 Optical interleaver
02/06/2003CA2452159A1 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods
02/05/2003EP1281702A2 Calcium receptor active molecules
02/05/2003EP1280765A2 Fluorous tagging compounds and their use
02/05/2003EP1280763A1 Trimethyldecenyl compounds
02/05/2003EP1280757A2 New gamma selective retinoids
02/05/2003EP1082121A4 Hiv integrase inhibitors
02/05/2003CN1395556A Monohydrate of cis-lithium-cyano-4-[3-(cyclopentyloxy)-4-methoxyphenyl] cyclohexanecarboxylate
02/05/2003CN1394855A Substituted heterocyclic compound
02/05/2003CN1100754C Method for producing trifluoroacetoacetic acid anilides
02/05/2003CN1100752C Manufacturing process for 6-aminocapronitrile
02/05/2003CN1100751C Novel glycine derivatives, their preparing method and use
02/04/2003US6515162 Method of preparing retroviral protease inhibitor intermediates
02/04/2003US6515161 Hydroformylation process utilizing multidentate phosphite ligands
02/04/2003US6515142 Intermediates of aromatic amidine derivatives which have anticoagulation action
02/04/2003US6515027 Substituted benzanilides as CCR5 receptors ligands, antiinflammatory agents and antiviral agents
02/04/2003US6514902 Method for producing an oxide catalyst for use in producing acrylonitrile or methacrylonitrile from propane or isobutane
02/04/2003US6514579 TN and STN liquid crystal displays
02/04/2003CA2271566C Substituted phenyl pyrimidines useful in the treatment of cns disorders
02/04/2003CA2059233C Carbonylation of olefins
01/2003
01/30/2003WO2003008393A1 Method for producing lamotrigine from alpha-oxo-2,3-dichlorophenyl acetamidino-aminoguanidino hydrazone by ring closure reaction
01/30/2003WO2003008096A1 Catalyst for the selective oxidation and ammoxidation of alkanes and/or alkenes, particularly in processes for obtaining acrylic acid, acrylonitrile and the derivatives thereof
01/30/2003WO2003007933A1 Napthoquinone derivatives as inhibitors of tau aggregation for the treatment of alzheimer's and related neurodegenerative disorders
01/30/2003WO2003007906A1 Photostable organic sunscreen compounds with antioxidant properties and compositions obtained therefrom
01/30/2003US20030023110 Reacting an acyclic, aliphatic, monoethylenically unsaturated compound with a source of HCN in the presence of a catalyst precursor composition comprising a Lewis acid, a zero- valent nickel, and a multidentate phosphite ligand for hydrocyanation
01/30/2003US20030023096 Useful as anti-hyperlipemia, for the prevention of abortion, for analgesics, as antidiarrheals, sleep inducer, diuretic, anti-diabetes, abortient, cathartics, antiulcer, anti-gastritis or antihypertensive etc.
01/30/2003US20030023083 Method for separating an azepine derivative out of a mixture containing an amine an azepine derivative
01/29/2003EP1279662A1 Process for preparing phenylcyclohexan-1-ylcarboxylic acids
01/29/2003EP1278758A1 Combretastatin a-1 phosphate and combretastatin b-1 phosphate prodrugs
01/29/2003EP1278720A1 1,4-diaryl-2-fluoro-4-cyano-2-butenes, process for their preparation and intermediates useful therefor
01/29/2003EP1278719A1 Naphthamide neurokinin antagonists for use as medicaments
01/29/2003EP0754175B1 Alkoxy-alkyl-substituted 1-h-3-aryl-pyrrolidine-2,4-diones used as herbicides and pesticides
01/29/2003CN1393440A Process for preparing catalyst used for oxidizing ammonia
01/29/2003CN1100035C Process for preparation of cyanoacrylmethylamine
01/29/2003CN1100034C Process for preparing unsaturated nitrile
01/28/2003US6512136 Substituted 2-phenyl-1-(3,4-dihydroxy-5-nitrophenyl)-1-ethanones, their use in the treatment of some central and peripheral nervous system disorders and pharmaceutical compositions containing them
01/23/2003WO2003006628A2 Nad synthetase inhibitors and uses thereof
01/23/2003WO2003006425A2 Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
01/23/2003WO2003006424A1 Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
01/23/2003WO2003006151A1 Microencapsulated catalyst, methods of preparation and methods of use thereof
01/23/2003WO2003006021A1 Alpha-hydroxyamide statine derivatives for the treatment of alzh eimer's disease
01/23/2003WO2003006013A1 Diaminediols for the treatment of alzheimer's disease
01/23/2003WO2002046138A3 Synthesis, methods of using, and compositions of hydroxylated cyclobutylalkylamines
01/23/2003WO2002022559A3 2-amino-2-alkyl-4 hexenoic and hexynoic acid derivatives useful as nitric oxide synthase inhibitors
01/23/2003US20030018209 Catalyzing the nitriding reaction of halogenoaromatics or aryl perfluorosulfonates and alkali metal cyanides
01/23/2003US20030018208 Halogen promoted multi-metal oxide catalyst
01/23/2003US20030018207 Pharmaceutical medication associated with insulin resistance; patient with prophylaxis conditions having reduced sensitivity to insulin
01/23/2003US20030018204 Halogen-containing aromatic acid dianhydride, halogen-containing aromatic tetranitrile compound, haltogen-containing aromatic tetracarbonxylic acid and halogen containing m-phenylenediamine compound
01/23/2003US20030018203 2-hydroxy-3-aryls or heteroaryls-2-yl-1,1-dimethyl-ethylamino)-propoxy)-phenyl derivatives useful for treating bone or mineral disease such as osteosarcoma, periodontal disease, osteoporosis, paget's disease
01/23/2003US20030018200 Preparation of isoxazolin-3-ylacylbenzenes
01/23/2003US20030018192 Preparation of substituted aromatic compounds
01/23/2003US20030018059 Antiinflammatory agents; antihistamines; antiallergens
01/23/2003US20030018016 Cell adhesion inhibitors
01/23/2003US20030017944 Mixed oxide catalyst
01/23/2003CA2453447A1 Alpha-hydroxyamide statine derivatives for the treatment of alzheimer's disease
01/23/2003CA2453444A1 Diaminediols for the treatment of alzheimer's disease
01/23/2003CA2453113A1 Microencapsulated catalyst, methods of preparation and methods of use thereof
01/23/2003CA2452491A1 Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
01/22/2003EP1277771A2 Living polymerisation process for the production of sequenced polymers using functional radical initiators
01/22/2003EP1277751A1 2- and 2,5-substituted phenylketo-enols
01/22/2003EP1277749A1 2- and 2,5-substituted phenylketo enols
01/22/2003EP1277735A1 2- and 2,5-substituted phenylketo-enols